| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |